Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FR.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FR.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FU.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FU.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBL.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBL.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBL.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBL.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.24.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.24.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.24.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.24.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.9.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.9.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.9.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FE.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FE.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FE.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FE.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FR.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FR.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FR.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GY.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GY.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBC.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBC.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used